Valuation: Novonesis A/S

Market Cap 213B 31.94B 28.54B 26.21B 23.81B 44.71B 3,026B 45.83B 313B 126B 1,597B 120B 117B 5,062B P/E 2026 *
38.9x
P/E 2027 * 33.3x
Enterprise Value 234B 35.01B 31.28B 28.73B 26.1B 49B 3,317B 50.24B 343B 138B 1,751B 131B 129B 5,548B EV / Sales 2026 *
7x
EV / Sales 2027 * 6.46x
Free-Float
74.08%
Yield 2026 *
1.59%
Yield 2027 * 1.78%
1 day+1.13%
1 week-0.54%
Current month+0.15%
1 month+8.62%
3 months+11.33%
6 months+15.99%
Current year+13.46%
1 week 448
Extreme 448
470.8
1 month 419
Extreme 419
481.5
Current year 336.8
Extreme 336.8
481.5
1 year 336.8
Extreme 336.8
481.5
3 years 331
Extreme 331
489.4
5 years 274.6
Extreme 274.6
545.8
10 years 220.7
Extreme 220.7
545.8
Date Insider Type Main position Quantity % Market Cap. Importance
11/21/25 Buy

Director

2,500 0.0006%
11/21/25 Buy

Director

2,500 0.0006%
11/7/25 Buy

Head of Human Resources

380 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+1.13%-0.54%+21.16%+36.85% 31.94B
-1.20%+4.60%+18.35%+74.33% 85.45B
+1.85%+2.71%+22.79%+32.32% 44.43B
+1.28%+5.51%+24.35%-17.38% 35.79B
+1.16%+5.24%+16.12%+20.88% 34.67B
-1.59%-0.76%-3.97%+18.71% 26.18B
+0.03%+0.65%+59.72%+40.35% 24.23B
+8.61%+11.47%+47.46%-26.58% 20.72B
-1.76%-10.93%+10.54%+7.89% 15.34B
+0.92%+4.92%+32.11%+0.71% 14.3B
Average +1.43%+1.31%+24.86%+18.81% 33.31B
Weighted average by Cap. +0.86%+2.23%+22.92%+30.37%

Financials

2026 *2027 *
Net sales 33.39B 5B 4.47B 4.1B 3.73B 7B 474B 7.18B 49B 19.71B 250B 18.78B 18.37B 793B 35.96B 5.39B 4.81B 4.42B 4.01B 7.54B 510B 7.73B 52.77B 21.23B 269B 20.22B 19.79B 854B
Net income 5.44B 814M 728M 668M 607M 1.14B 77.15B 1.17B 7.98B 3.21B 40.72B 3.06B 2.99B 129B 6.38B 956M 854M 785M 713M 1.34B 90.59B 1.37B 9.37B 3.77B 47.82B 3.59B 3.51B 152B
Net Debt 20.5B 3.07B 2.74B 2.52B 2.29B 4.3B 291B 4.41B 30.08B 12.1B 154B 11.53B 11.28B 487B 18.98B 2.84B 2.54B 2.33B 2.12B 3.98B 269B 4.08B 27.85B 11.2B 142B 10.67B 10.44B 451B
Projected Income Statement - Annual - Novonesis A/S
Logo Novonesis A/S
Novonesis A/S is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market as follows: - agriculture, bioenergy and animal feed industries (35.8%); - food industries (33%); - cleaning and household care products industries (19.3%); - human nutritional health industries (11.9%). Net sales are geographically distributed as follows: Denmark (1.1%), Europe/Middle East/Africa (34.6%), North America (32%), Asia/Pacific (18.7%), and Latin America (13.6%).
Employees
11,098
Date Price Change Volume
26-11-04 DKK 462.70 +1.09% 230,975
26-11-03 DKK 457.70 -0.82% 551,999
26-11-02 DKK 461.50 -0.11% 604,888
26-10-30 DKK 462.00 -0.71% 1,071,431
26-10-29 DKK 465.30 +0.02% 593,893
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Novonesis A/S
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
457.70DKK
Average target price
501.00DKK
Spread / Average Target
+9.46%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Novonesis A/S
  1. Stock Market
  2. Stocks
  3. NSIS B Stock